nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Averting catastrophic tuberculosis costs in an Indian state: integration of Ayushman Bharat Arogya Karnataka with National Tuberculosis Elimination Program
|
Shastri, Suresh G. |
|
|
22 |
C |
p. |
artikel |
2 |
Call for action: presenting constituency-level data on population, health and socioeconomic wellbeing related to 2030 Sustainable Development Goals for India
|
Subramanian, S.V. |
|
|
22 |
C |
p. |
artikel |
3 |
Characteristics and clinical outcomes of patients with pre-delta, delta and omicron SARS-CoV-2 infection in Indonesia (2020–2023): a multicentre prospective cohort study
|
Karuniawati, Anis |
|
|
22 |
C |
p. |
artikel |
4 |
Coverage gaps in empiric antibiotic regimens used to treat serious bacterial infections in neonates and children in Southeast Asia and the Pacific
|
Williams, Phoebe C.M. |
|
|
22 |
C |
p. |
artikel |
5 |
Estimating the proportion of relapse following treatment of Visceral Leishmaniasis: meta-analysis using Infectious Diseases Data Observatory (IDDO) systematic review
|
Chhajed, Rutuja |
|
|
22 |
C |
p. |
artikel |
6 |
Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study
|
Asokan, Mangaiarkarasi S. |
|
|
22 |
C |
p. |
artikel |
7 |
Indonesia's first suicide statistics profile: an analysis of suicide and attempt rates, underreporting, geographic distribution, gender, method, and rurality
|
Onie, Sandersan |
|
|
22 |
C |
p. |
artikel |
8 |
Management of drug-resistant tuberculosis in Indonesia: a four-year cascade of care analysis
|
Lestari, Bony Wiem |
|
|
22 |
C |
p. |
artikel |
9 |
Protection of staff and families during COVID-19 pandemic: experience from a research institute in Bangladesh
|
Nuzhat, Sharika |
|
|
22 |
C |
p. |
artikel |
10 |
Safety and efficacy of mycophenolate in COVID-19
|
Zeng, Guangting |
|
|
22 |
C |
p. |
artikel |
11 |
Self-driven solutions and resilience adapted by people with drug-resistant tuberculosis and their caregivers in Bengaluru and Hyderabad, India: a qualitative study
|
Nagarajan, Karikalan |
|
|
22 |
C |
p. |
artikel |
12 |
Shortening delays in seeking aid for cardiovascular events: a step beyond
|
Lang, Xi |
|
|
22 |
C |
p. |
artikel |
13 |
The availability of essential medicines in primary health centres in Indonesia: achievements and challenges across the archipelago
|
Fanda, Relmbuss Biljers |
|
|
22 |
C |
p. |
artikel |
14 |
The burden of dengue and force of infection among children in Kerala, India; seroprevalence estimates from Government of Kerala-WHO Dengue study
|
Indu, Pillaveetil Sathyadas |
|
|
22 |
C |
p. |
artikel |
15 |
Trials Methodology Research: what is it and why should India invest in it?
|
Paramasivan, Sangeetha |
|
|
22 |
C |
p. |
artikel |
16 |
Tuberculosis – eliminating the latent killer
|
The Lancet Regional Health – Southeast Asia, |
|
|
22 |
C |
p. |
artikel |